Nivalis Therapeutics, Inc. (NASDAQ : NVLS) announced that its Board of Directors has initiated a process to explore and review ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE